Skip to main content

CORRECTION article

Front. Microbiol., 15 September 2016
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 7 - 2016 | https://doi.org/10.3389/fmicb.2016.01464
This article is part of the Research Topic New Frontiers in the Search of Antimicrobials Agents From Natural Products, Volume II View all 67 articles

Corrigendum: Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus

This article is a correction to:

  1. Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus

    1. Read original article
\r\nChangbo Ou&#x;Changbo Ou1†Qiang Zhang&#x;Qiang Zhang2†Juan WangJuan Wang3Guojiang WuGuojiang Wu4Ningning ShiNingning Shi5Cheng He*Cheng He2*Zengping Gao*Zengping Gao3*
  • 1College of Animal Science, Henan Institute of Science and Technology, Xinxiang, China
  • 2Key Lab of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing, China
  • 3School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China
  • 4College of Life Science, Agricultural University of Hebei, Baoding, China
  • 5College of Pharmacy, Hebei Medical University, Shijiazhuang, China

A corrigendum on
Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus

by Ou, C., Zhang, Q., Wu, G. J., Shi, N., and He, C. (2015). Front. Microbiol. 6:592. doi: 10.3389/fmicb.2015.00592

In the original research article, Juan Wang and Zengping Gao were not included in the author list. They have now been included along with the affiliation: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

In addition, Zengping Gao has been included as a corresponding author.

Finally, the authors unintentionally did not acknowledge funding from the National Natural Science Foundation of China No.31270400.

The authors apologize for these oversights. These errors do not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: dryocrassin ABBA, influenza virus H5N1, phloroglucinol compound, antiviral activity, Rhizoma Dryopteridis Crassirhizomatis, amantadine

Citation: Ou C, Zhang Q, Wang J, Wu G, Shi N, He C and Gao Z (2016) Corrigendum: Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus. Front. Microbiol. 7:1464. doi: 10.3389/fmicb.2016.01464

Received: 20 August 2016; Accepted: 01 September 2016;
Published: 15 September 2016.

Edited and reviewed by: Luis Cláudio Nascimento Da Silva, CEUMA University, Brazil

Copyright © 2016 Ou, Zhang, Wang, Wu, Shi, He and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Cheng He, hecheng@cau.edu.cn
Zengping Gao, gaozengping0812@163.com

†These authors have contributed equally to this work.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.